Sucralfate Paten

Sucralfate Paten. Sucralfate is indicated for shortterm treatment (up to 8 weeks) of active duodenal ulcerWhile healing with sucralfate may occur during the first week or two treatment should be continued for 4 to 8 weeks unless healing has been demonstrated by Xray or endoscopic examination Sucralfate is also indicated for maintenance therapy for duodenal ulcer patients.

US4885281A US07/171347 US17134788A US4885281A US 4885281 A US4885281 A US 4885281A US 17134788 A US17134788 A US 17134788A US 4885281 A US4885281 A US 4885281A Authority US United States Prior art keywords sucralfate suspensions weight xanthan gum formulations Prior art date 19840822 Legal status (The legal status is an assumption.

Sucralfate suspension Merck, Patent Gesellschaft Mit

Sucralfate comes as a tablet and liquid to take by mouth If you are taking sucralfate to treat ulcers the tablets or liquid usually are taken four times a day If you are taking sucralfate to prevent an ulcer from returning after it has healed) the tablets usually are taken twice a day Take sucralfate on an empty stomach 2 hours after or 1 hour before meals Take sucralfate.

Sucralfate for Dogs

When it is to be synthesize sucralfate may be produced by the methods described in for example Japanese Patent Publication Nos 11673/1969 16037/1969 and 76927/1993 International Publication WO 9204030 etc The wet powder which is obtained in each of the synthesis procedures or the sucralfate obtained by drying said powder may also be employed.

Sucralfate Oral Patient Medicine Information MIMS

US5648092A US07/732523 US73252391A US5648092A US 5648092 A US5648092 A US 5648092A US 73252391 A US73252391 A US 73252391A US 5648092 A US5648092 A US 5648092A Authority US United States Prior art keywords sucralfate sugar pharmaceutical composition tablets gel former Prior art date 19900719 Legal status (The legal status is an.